Aaron Cox - 27 Dec 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
EVP, Chief Financial Officer
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
27 Dec 2022
Net transactions value
$0
Form type
4
Filing time
29 Dec 2022, 15:23:08 UTC
Previous filing
16 May 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Award +277 +5.8% 5,051 01 Jun 2022 Direct F1
transaction HZNP Ordinary Shares Gift $0 -4,774 -95% $0.000000 277 15 Dec 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Performance Restricted Stock Units (PSUs) Award $0 +17,416 $0.000000 17,416 27 Dec 2022 Ordinary Shares 17,416 Direct F2, F3
transaction HZNP Performance Restricted Stock Units (PSUs) Award $0 +13,972 $0.000000 13,972 27 Dec 2022 Ordinary Shares 13,972 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 277 ordinary shares of the Issuer acquired by the reporting person on June 1, 2022 pursuant to an employee stock purchase program.
F2 Each PSU represents a contingent right to receive one ordinary share of the Issuer.
F3 On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met. The ordinary shares subject to the PSUs vest on December 30, 2022.
F4 On January 4, 2021, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on December 30, 2022, and the remaining one-third of the ordinary shares vest on January 5, 2024.